Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.
about
Reactivity to laboratory stress provocation predicts relapse to cocaineNeuropeptide regulation of the locus coeruleus and opiate-induced plasticity of stress responsesUltrastructural evidence for co-localization of corticotropin-releasing factor receptor and mu-opioid receptor in the rat nucleus locus coeruleusThe effects of opioids and opioid analogs on animal and human endocrine systemsEffects of sleep deprivation on sleep homeostasis and restoration during methadone-maintenance: a [31]P MRS brain imaging studyPsychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenancePsychoticism and neuroticism predict cocaine dependence and future cocaine use via different mechanisms.Opioids, dopamine, stress, and the addictions.Elevated Hair Cortisol Levels among Heroin Addicts on Current Methadone Maintenance Compared to ControlsMaintenance medication for opiate addiction: the foundation of recovery.Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.Role of a functional human gene polymorphism in stress responsivity and addictionsIllicit drug use among women with children in the United States: 2002-2003.Response to corticotropin-releasing hormone infusion in cocaine-dependent individualsNaltrexone and buprenorphine combination in the treatment of opioid dependence.Reliability of salivary cortisol assessments in cocaine dependent individuals.Morphine Withdrawal Increases Brain-Derived Neurotrophic Factor Precursor.Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
P2860
Q24655024-DC693722-F039-4DD8-B265-8D8018FA468EQ26830264-24449E9B-D541-4395-8681-0F35B54909CEQ28564143-64126D06-D0B2-4418-AB99-01912DCE324BQ33779667-9613E209-E492-4376-BBC5-DD64CB4841C3Q33932225-90C1212B-1246-48CB-A030-4EF59D5C2639Q34602839-B328FACC-7443-4922-A88E-5AC27DB1FFCFQ35017227-9ADD3A72-EF0E-477E-BC4D-1D5DE1C96894Q35454821-F629153D-A16B-4B8D-B18D-3498C6B53286Q35969069-C876E47E-951E-47D7-831A-CDCC52F3C014Q36138164-0D24761C-E96B-4E7F-BFB2-8F5556B2B6F6Q36499673-DFA9786E-2907-4313-A759-D8BC1B5D81CBQ37103624-661CDDD0-3335-4092-AA77-334A7BDBF3F5Q37186941-E79097EC-DED8-4D96-B06F-5784FC4289D1Q37227233-68ECB509-0379-4C71-9CAA-1F2D1F9ECF42Q44351532-21917553-800E-4FCE-A72F-7D91D697C447Q46988497-D6CF647D-E204-45DA-A962-F5F53FC28F30Q47992008-551B05E9-7C60-4BF9-A2DF-5AFFA927DFEFQ58788199-97714C72-3774-4513-8D3A-1B466453F1A1
P2860
Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Corticotropin-releasing factor ...... aintained vs control subjects.
@en
Corticotropin-releasing factor ...... aintained vs control subjects.
@nl
type
label
Corticotropin-releasing factor ...... aintained vs control subjects.
@en
Corticotropin-releasing factor ...... aintained vs control subjects.
@nl
prefLabel
Corticotropin-releasing factor ...... aintained vs control subjects.
@en
Corticotropin-releasing factor ...... aintained vs control subjects.
@nl
P2093
P2860
P356
P1476
Corticotropin-releasing factor ...... aintained vs control subjects.
@en
P2093
Gavin Bart
James H Schluger
Mark Green
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300156
P407
P577
2003-03-26T00:00:00Z